TRANS2CARE Transregional Network for Innovation and Technology Transfer to Improve Health Care (INTERREG SLOVENIA – ITALY 2007 – 2013)

Duration of the project:

1. 4. 2011 – 30. 9. 2014

Leading Partner:

University of Trieste

Project Partners:

University of Primorska, Faculty of Health Sciences
National Institute of Chemistry – Laboratory of Chemometrics
International School for Advanced Studies – Laboratory of Prion Biology
University of Nova Gorica – Laboratory of Environmental Research
University of Ferrara – Experimental and Clinical Medicine Department
Agency for Innovation Treviso Chamber of Commerce
General hospital of Nova Gorica – Intensive Care Unit and Cardiology
University Ca’ Foscari Venice – Dept. Of Molecular Sciences and Nanosystems
University of Udine – DISA and DSMB
Institute of Child Health IRCCS “Burlo Garofolo” Trieste
Blood Transfusion Centre of Slovenia
Valdoltra Orthopaedic Hospital
University of Primorska, Faculty of Health Sciences

Team manager at UP FHS:

Prof. Maja Čemažar (SICRIS, ResearchGate)

Researcher:

Ana Petelin (SICRIS, ResearchGate)

Summary:

Trans2Care project involves and integrates the expertise of 13 research, education, healthcare and technology transfer Institutions.
It aims at establishing a permanent, bi-directional flow of knowledge transfer among the project partners, industry and other stakeholders, so to establish an environment generating innovative products and services for the public healthcare system. In particular, the project addresses questions about prevention, diagnosis and treatment of widespread diseases.
Innovations will be developed on the basis of unmet medical needs expressed by the healthcare personnel; they will be made possible thanks to the close interaction among researchers and industry, so translating scientific and technological expertise into products.
These innovations will enable the improvement of healthcare system and the creation of new jobs for highly qualified young workers.
The project will also aim to ensure the sustainability of the partnership beyond the end of its activities.

Accessibility